Spotfire Expands DecisionSite Product Family

Spotfire, a leading provider of eAnalytic software and services, expanded its Spotfire DecisionSite family of eAnalytic applications with the launch of its first role-based application for product development, Spotfire DecisionSite for Lead Discovery. The first integrated Web-based application of its kind, Spotfire DecisionSite for Lead Discovery is designed to capitalize on the substantial market opportunity presented by the biotechnology and pharmaceuticals industries.

Spotfire DecisionSite for Lead Discovery specifically addresses the needs of people involved in new product development within life sciences organizations. It equips researchers and scientists to make breakthrough discoveries that could lead to the next blockbuster drug. This expansion of the Spotfire DecisionSite product line underscores Spotfire's commitment to provide decision makers in various roles with powerful analytic applications that support effective decision-making.

"The expansion of the Spotfire DecisionSite product line accentuates Spotfire's strategy to address the complexities associated with accessing and analyzing back-office information," said Dr. Christopher Ahlberg, Spotfire founder and CEO. "This commitment, coupled with customer demand for Web-based analytic applications that address the needs of employees across business functions, is the driving force behind faster, better and more accurate decisions. Spotfire DecisionSite for Lead Discovery is the first in a number of role-based applications we will develop to serve people in such areas as new product research, development, and manufacturing."

Spotfire DecisionSite for Lead Discovery offers these key capabilities to researchers and scientists in the life sciences market:

• Information interaction -- The application links to and integrates important research information in a very fast way. Users can easily query internal and external data repositories, and integrate biological, chemical and physical property data into the discovery process.
• High-impact analytics -- The application provides an array of Web-delivered analytic tools for data reduction activities specific to the drug discovery process.
• Reporting and decision sharing -- The application provides the ability for colleagues to generate and share high-quality reports, regardless of geographic location.
• A dynamic user experience - Spotfire's browser-based environment and patented visual analysis capabilities present simultaneous views of disparate information and query devices for intuitive, interactive analysis.

Spotfire DecisionSite for Lead Discovery builds on the powerful functionality of the Spotfire DecisionSite application, launched in early February. Spotfire DecisionSite is a highly configurable eAnalytic application for end users offering interactive visualization, a powerful user interface, and unprecedented ease to the access, exploration and analysis of large disparate data sets.

Product Availability

The Spotfire DecisionSite for Lead Discovery application, available on April 20, is available with one and three-year subscription licenses.

About Spotfire

Spotfire Inc is a leading provider of eAnalytic applications and services that put the power of decision-making at the center of its customers' businesses. Spotfire's solutions enable organizations around the world to improve the efficiency, the speed and the accuracy of their decision-making processes by advancing both individual and networked analysis. More than 350 customers and over 16,000 subscribers use Spotfire products worldwide. The company maintains U.S. headquarters in Cambridge, Mass. and European headquarters in Goteborg, Sweden. Additional information can be found at www.spotfire.com.

Contact Spotfire Inc, Michael Akillian, 617-621-0340 x111, mike.akillian@spotfire.com.